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Abstract
Background
Intrauterine infection is a primary cause of preterm birth and fetal injury. The pro-inflamma-
tory role of the fetal skin in the setting of intrauterine infection remains poorly characterized.
Whether or not inflammation of the fetal skin occurs in primates remains unstudied. Accord-
ingly, we hypothesized that: i) the fetal primate skin would mount a pro-inflammatory
response to preterm birth associated pro-inflammatory agents (lipopolysaccharides from
Escherichia coli, live Ureaplasma parvum, interleukin-1β) and; ii) that inhibiting interleukin-1
signaling would decrease the skin inflammatory response.
Methods
Rhesus macaques with singleton pregnancies received intraamniotic injections of either
sterile saline (control) or one of three pro-inflammatory agonists: E. coli lipopolysaccharides,
interluekin-1β or live U. parvum under ultrasound guidance. A fourth group of animals
received both E. coli lipopolysaccharide and interleukin-1 signaling inhibitor interleukin-1
receptor antagonist (Anakinra) prior to delivery. Animals were surgically delivered at approx-
imately 130 days’ gestational age.
Results
Intraamniotic lipopolysaccharide caused an inflammatory skin response characterized by
increases in interluekin-1β,-6 and -8 mRNA at 16 hours. There was a modest inflammatory
response to U. parvum, but interleukin-1β alone caused no inflammatory response in the
fetal skin. Intraamniotic Anakinra treatment of lipopolysaccharide-exposed animals signifi-
cantly reduced skin inflammation.
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Conclusions
Intraamniotic lipopolysaccharide and U. parvum were associated with modest increases in
the expression of inflammatory mediators in primate fetal skin. Although administration of
Interleukin-1β alone did not elicit an inflammatory response, lipopolysaccharide-driven skin
inflammation was decreased following intraamniotic Anakinra therapy. These findings pro-
vide support for the role of the fetal skin in the development of the fetal inflammatory
response.
Introduction
Preterm birth (delivery before 37 weeks’ gestation) is implicated in more than 1 million perina-
tal deaths worldwide each year [1]. Fetal and intrauterine inflammation cause preterm labor,
and the presence of a systemic fetal inflammatory response at delivery is also associated with
increased risk of adverse neonatal respiratory and central nervous system outcomes [2]. Identi-
fying the gestational tissues responsible for generating intrauterine inflammation is thus an
important step in advancing both our understanding of the aetiology of preterm birth and in
the development of potential anti-inflammatory interventions.
A large literature describes the pro-inflammatory responses of the fetal lung and the
chorioamnion to pro-inflammatory stimulation. However, the role of the fetal skin in driv-
ing intrauterine and fetal inflammation is less clear. The fetal skin is a large and highly vas-
cularized immunologically competent organ [3, 4] that is continuously exposed to amniotic
fluid in utero. Amniotic fluid can contain pathogenic microorganisms [5] and proinflam-
matory mediators associated with preterm labor and delivery including interleukins (IL)-
1β, IL-6, IL-8 and tumour necrosis factor (TNF)-α [2, 6, 7]. Amniotic contents thus can
interact with fetal skin by direct exposure, with the fetal gut epithelium by swallowing, and
the fetal lung by fetal breathing and aspiration [8]. The skin has innate host defense systems
to augment barrier function [9], but little is known about host defense in the skin of the pre-
term fetus, which in early gestation has minimal cornification and comparatively reduced
barrier function [10].
Using sheep models of chorioamnionitis induced by the intraamniotic (IA) administration
of E.coli lipopolysaccharide (LPS) or live Ureaplasma parvum (UP) we reported that the fetal
skin responded with increased inflammatory cells and cytokine expression in the dermis [11–
13]. With isolation of the oral and nasal epithelium and the fetal lungs and gut, an intra-amni-
otic exposure to LPS induced a systemic inflammatory response, likely mediated, at least in
part, by inflammation in the fetal skin [14]. In contrast, exposure of only the fetal gut did not
induce a systemic fetal inflammatory response [15].
There is very little information about how the fetal human or primate skin will respond to
chorioamnionitis. We recently reported that intra-amniotic injection of LPS or IL-1β given to
rhesus macaques with preterm pregnancies caused acute inflammation in the decidua, amni-
otic fluid, fetal lung and induced fetal inflammatory responses [16]. More chronic exposure to
live Ureaplasma parvum caused minimal and inconsistent chorioamnionitis in the rhesus [17].
In the present report we asked if the fetal primate skin would mount a proinflammatory
response to either LPS, live UP and recombinant IL-1β, three clinically relevant proinflamma-
tory mediators associated with prematurity. We also sought to determine the importance of
IL-1 signalling to a putative skin inflammatory response by the co-administration of LPS and
the IL-1 receptor antagonist (IL-1ra) Anakinra.
Skin inflammation in the primate fetus
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Colony forming unit; CCL2, Chemokine ligand 2;
ELISA, Enzyme-linked immunosorbent assay;
MCP-1, Monocyte Chemoattractant Protein-1;
MPO, Myeloperoxidase; PBS, Phosphate buffer
saline.
Materials and methods
Animals
All animal procedures were approved by the Institutional Animal Care and Use commit-
tee at the University of California, Davis (18562) with use of approved standard operating
procedures for Rhesus macaque (Macaca Mulatta). Time mated pregnant females were
sedated with ketamine at approximately 125 to 130 days of gestation (term is 165 days)
for ultrasound directed IA injections. Cesarean section deliveries followed sedation and
pre-anesthesia for surgical field preparation and isoflurane anesthesia. Briefly, dams were
sedated with an intramuscular injection of ketamine (10 mg/kg). The dams were then
intubated, connected to an electrocardiogram monitor, and anaesthesia was maintained
with inhalation isofluorane (1–2% fresh gas flow). Intravenous crystalloid solution (0.9%
NaCl) was provided at a rate of 10 mL/kg/hour. Heart rate, respiratory rate, oxygen satu-
ration, and depth of anaesthesia (jaw tone, corneal and palpebral reflexes, limb with-
drawal reflex) were constantly monitored during the procedure. The fetus was removed
in cull for recovery of gestational tissues and amniotic fluid, and euthanized with intrave-
nous pentobarbital. The dam then received an intramuscular injection of atropine (0.04
mg/kg). Anaesthesia was withdrawn at the end of the procedure and dams were recovered
with supplemental oxygen provided until airway control was regained. The dam’s appe-
tite, hydration, stool quality, pain score, and incision site appearance was observed and
recorded postoperatively for at least seven days. Intramuscular oxymorphone (0.15 mg/
kg; administered between one and three times each day) was provided under veterinary
direction based on clinical need.
The treatments were as follows:
1. LPS: LPS (1mg, E. coli O55:B5, Sigma Aldrich, Saint Louis, MO) in 1 mL of sterile saline
solution was given by ultrasound-guided IA injection. After either 16 or 48 hours, fetuses
were surgically delivered for fetal tissue collection;
2. Ureaplasma: Rhesus macaque dams were injected intra-amniotically with 107 CFU Urea-
plasma parvum (UP) serovar 1[17] under ultrasound gudiance. Fetuses were delivered sur-
gically either 3 or 7 days later;
3. IL-1β: Rhesus macaque dams received 10 μg human recombinant IL-1β (Peprotech, Rocky-
hill, NJ) in 1 ml sterile saline or 1 ml sterile saline by ultrasound guided intra-amniotic
injection [16] and were delivered either 1 or 3 days later; and
4. LPS and IL-1ra: LPS (1mg, E. coli O55:B5, Sigma Aldrich, Saint Louis, MO) in 1 mL of
sterile saline solution was given by ultrasound-guided IA injection. 50mg IA and 100mg
subcutaneous (SC) IL-1ra (Anakinra Sobi, Stockholm, Sweden) was given to pregnant
monkeys at 1 and 3 hours, respectively before IA LPS administration. Fetuses were surgi-
cally delivered for fetal tissue collection after either 16 or 48 hours.
The variation in time to delivery between groups reflects the difference in the nature of the
anticipated inflammatory response generated by different agonists, and to assess inflammatory
responses at acute and also longer-term time points. Animals that were delivered 48 hours
after IA LPS received a second IA + SC IL-1ra treatment, administered 24 hours after the first
treatment. Matched saline controls were established for each of the four treatment groups.
Samples of skin from the groin were fixed in 10% formalin for histological analysis, or snap
frozen in liquid nitrogen for mRNA studies.
Skin inflammation in the primate fetus
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mRNA quantitation
Total RNA was isolated from frozen skin samples by homogenization with TRIzol (Invitrogen,
Carlsbad, CA) and column purification with RNeasy Universal Mini Kits (Qiagen, Valencia,
CA) according to the manufacturer’s instructions. Reverse transcription was performed using
Verso cDNA kit (Thermo Scientific, Waltham, MA). The relative expression of IL-1β, TNF-α,
IL-6, IL-8, IL-10, IL-1α, IL-17α and monocyte chemoattractant protein 1 (MCP-1) was deter-
mined by rt-PCR using the cDNA template and rhesus macaque-specific Taqman probes and
primers (Applied Biosystems, Foster City, CA). The mRNA expression for each gene was nor-
malized to the mRNA for the 18s ribosomal protein as the endogenous control and a sample
from the control group was used as a calibrator. Data are expressed as fold increase over the
mean control value. Probe and primer set details are presented in Table 1.
Immunohistochemistry
Immunohistochemistry was performed with 5 μm thick sections of formalin fixed tissues.
Sections were de-paraffinized and rehydrated before microwave-assisted antigen retrieval
in citric acid buffer at pH 6.0. Endogenous peroxidase activity was reduced with CH3OH/
H2O2 treatment and the tissue was blocked with 4% normal goat serum in PBS. Sections
were incubated overnight at 4˚C with the primary antibody diluted in 4% serum in PBS.
The following primary antibodies were used: anti-myeloperoxidase (MPO, Cell Marque
289A-75, cat. # 1404306A, dilution 1:200), anti-CD3 (Dako Cytomation, A0452 cat. #
20024875, dilution, 1:100), anti-CD 68 (Biosciences Pharmingen, M0814, cat. # 24648, dilu-
tion 1:200), anti-IL-8 (BD Bioscience, cat. # 550419, dilution, 1:100), anti-IL-6 (Lifespan
Bioscience, Inc. LS-B7482 cat. # 37847, dilution, 1:400) and Anti-Pancytokeratin (Santa
Cruz Biotechnology, SC-81714, cat. # B1015, dilution, 1:2500), with dilutions made in 4%
normal goat serum. Sections were then washed and incubated with the appropriate species-
specific secondary antibody diluted 1:200 in 4% serum for 2 hours at room temperature.
After further washing, antigen:antibody complexes were visualized using a Vectastain ABC
peroxidase kit (Vector Laboratories Inc., Burlingame, CA). Antigen detection was enhanced
with nickel-diaminobenzidine, followed by incubation with Tris-1-cobalt. Slides were coun-
terstained with Nuclear Fast Red for photomicroscopy. Blinded digital images of the fetal
rhesus skin (5 non-overlapping, random fields per animal) were quantified for the total
number of inflammatory cells, and immunostaining for IL-6, IL-8, neutrophil (MPO),
monocyte/macrophage (CD68), and T-cells (CD3). Pancytokeratin staining intensity was
also quantified by a blinded investigator, based on color threshold and expressed as percent-
age of intense, moderate and no staining area relative to total area.
Table 1. Summary of PCR sets.
TaqMan Probe Assay ID
(Applied Biosystems)
Entrez Gene ID
IL-1β Rh02621711_m1 704701
IL-6 Rh02789322_m1 705819
IL-8 Rh02789781_m1 613028
TNF Rh02789783_m1 715467
IL-10 Rh00961619_m1 694931
IL-1α Rh02789770_m1 700193
IL-17A Rh02621750_m1 708123
MCP-1 Rh02621753_m1 574138
https://doi.org/10.1371/journal.pone.0184938.t001
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Cell counting
Sections stained for IL-6, IL-8, CD3 (T-cells), CD68 and MPO were counted for number of
positive cells in ten randomly-selected fields per animal on photomicrographs (40x objective
magnification) from the epidermal to dermal layers by an investigator blinded to treatment
groups. A similar strategy was used to determine the percentage of cells positively stained for
pancytokeratin (1:2,500), to determine both the number and the percentage cells with either
intense, moderate or no staining.
Statistical analyses
GraphPad Prism (GraphPad Software 5.Ink, La Jolla, CA) was used to graph and analyze data
for statistical significance. Data are presented as means ± SEM (standard error of the mean).
Data were tested for normality and variance; statistical differences between groups were ana-
lyzed using Mann–Whitney U tests. Values of p<0.05 were considered significant.
Results
Animals
There was no preterm labor or evident abnormalities in animals from either the four treatment
groups or matched saline controls. Gestational ages at birth and birth weights were similar
among the animals (Table 2). Mean fetal weights at tissue collection were not different between
groups.
IA LPS, UP but not IL-1β increase cytokine expression in the fetal rhesus
skin
IL-1β, IL-6 and IL-8 mRNA significantly increased 16 hours after IA LPS (p<0.05). Only IL-8
mRNA remained significantly elevated 48h after LPS exposure (Fig 1, panels a-c). The cytokines
TNF-α, IL-1α, and MCP-1 did not change with LPS exposure, and IL-10 was undetectable in
association with LPS exposure. In the UP treatment group, IL-1β mRNA was significantly
Table 2. Treatment groups Intra-amniotic injections of LPS, IL-1β, and Ureaplasma parvum (UP) or saline were performed in multiparous
macaques of similar weight and age. Separate animals were used for controls for each treatment group. Mean fetal weights at tissue collection were not dif-
ferent between groups.
Treatment N Gestational age (days) Birth Weight
(gm)
Sex
(M:F)
LPS and IL-1ra treatment
Saline Control 13 132±0.6 337±8 6:7
LPS-16h 11 132±0.7 326±12 6:5
LPS-48h 8 132±0.8 320±10 1:7
LPS and IL-1ra-16h 6 132±1.5 354±14 3:3
LPS and IL-1ra-48h 3 128±0.8 315±9 3:0
IL-1β treatment
Saline Control 5 131±1.1 310±9 0:5
IL-1β- 1d 5 130±0.7 341±13 3:2
IL-1β- 3d 4 129±0.3 346±38 1:4
UP treatment
Saline Control 5 132±0.9 343±4 3:2
UP-3d 5 130±1.1 348±19 2:3
UP-7d 5 130±0.5 341±8 2:3
https://doi.org/10.1371/journal.pone.0184938.t002
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increased by 25-fold at 3 days and IL-6 mRNA increased by 5-fold at 7 days after IA UP
(p<0.05, Fig 1, panels a and b). In contrast to LPS exposure, TNF-α increased significantly 15
fold at 3 days and 9 fold at 7 days, but IL-10, IL-1α, and MCP-1 did not change with UP expo-
sure (Table 3). IL-1β treatment did not significantly increase the mRNA expression of any of
the cytokines or chemokines measured at either time point.
IL-1ra decreased IL-1β and IL-8 mRNA expression in LPS exposed fetal
rhesus skin
In the LPS + IL-1ra treatment group, there were statistically significant decreases in IL-1β and IL-
8 mRNA expression at 16 hours (p<0.05, Fig 1, panels d and f) relative to LPS-treatment only.
IA LPS and the impact of IA IL-1ra on inflammatory mediators
We performed immunohistochemistry (IHC) for IL-6, IL-8, CD3, CD68, MPO and pancyto-
keratin. The number of cells positively stained for IL-6 and pancytokeratin increased
Fig 1. Cytokine PCR Analysis. Quantitative PCR analysis of cytokines in fetal rhesus macaque skin
following intra-amniotic exposure with LPS, IL-1β or UP and for different times of exposure (Panel a, b and c).
Cytokine expression for LPS and LPS plus IL-1ra exposure groups (Panel d, e and f). Graphs represent mean
mRNA fold change ± SD. *indicates a significant increase in transcript expression relative to untreated control
group normalized to a value for 1.0. ɸ indicates a significant decrease in transcript expression relative to LPS
at 16 hours.
https://doi.org/10.1371/journal.pone.0184938.g001
Table 3. Summary of cytokine / chemokine mRNA expression. Data are mean ± SD; *p = 0.05. Cells
without data represent transcript levels below limit of detection.
TNF IL-10 IL-1α MCP-1
Control 1.0±0.6 1.0±1.0 1.0 ±0.8 1.0±0.9
LPS 16h 1.3±0.8 - 2.5±3.9 1.4±0.8
LPS+IL-1RA 16h 1.2±0.6 - 1.8±1.4 1.8±0.6
LPS 48h 3.1±5.7 - 1.3±0.8 1.0±0.8
LPS+IL-1RA 48h 3.3±3.4 - 3.7±3.2 1.2±0.6
IL-1B 1d 1.7±1.4 2.3±2.6 1.7±1.7 0.7±0.3
IL-1B 3d 1.1±0.5 0.6±0.3 0.7±0.3 0.3±0.1
UP 3d 15.0±29.6* - 1.4±1.0 2.4±2.6
UP 7d 9.0±8.9* - 1.2±0.5 2.7±2.1
https://doi.org/10.1371/journal.pone.0184938.t003
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significantly 16 hours after IA LPS (p<0.05, Figs 2 and 3). We did not identify changes in the
other markers assessed. The administration of IL-1ra significantly decreased the number of IL-
6 positive cells (p<0.05, Fig 2). There was a significant increase in the percentage of intensely
positive pancytokeratin stained cells for the LPS group at 16 hours relative to the untreated
control group. At 16 hours, there was significant decrease in the percent of intense positive cell
after IA IL-1ra administration (p<0.05, Fig 3). There was no difference in moderate staining
Fig 2. IL-6 expression. Representative photomicrographs for IL-6 (1:400) immunohistochemical staining of
fetal skin. (A) control; (B) LPS at 16 h; (C) LPS and IL-1ra at 16 h exposure. (D) The number of positive cells
(arrow), that were counted between groups. (magnification bar represents 20 μm). *indicates a significant
increase in the number of positive cells relative to the untreated control. ɸ indicates a significant decrease in
number of positive cells relative to LPS.
https://doi.org/10.1371/journal.pone.0184938.g002
Fig 3. Pancytokeratin expression. Representative photomicrographs for pancytokeratin (1:2500) immu-
nohistochemical staining of fetal skin. (A) control; (B) LPS at 16 h; (C) LPS and IL-1ra at 16 h exposure. (D)
Graph shows the comparison between groups in the percent of positive cells of different intensity stain;
intense (arrow), moderate and no stain (magnification bar represents 20 μm). *indicates a significant
difference in the percent of positive cell between LPS at 16 hours and untreated control group. ɸ indicates a
significant difference in the percent of positive cell between LPS group and LPS plus IL-1ra group at 16 hours.
https://doi.org/10.1371/journal.pone.0184938.g003
Skin inflammation in the primate fetus
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of pancytokeratin IHC between groups. We did not observe infiltrating neutrophils (MPO),
leukocytes (CD3+) or infiltrating macrophages (CD68+) in fetal skin after IA LPS treatment.
Discussion
We demonstrate that the fetal rhesus skin is capable of generating an inflammatory response in
utero, in response to direct stimulation by both LPS and UP. In LPS-exposed animals, we show
that this response involves increased expression of mRNA transcripts for preterm birth-associ-
ated proinflammatory cytokines IL-1β, IL-6, and IL-8, and increased staining for IL-6 and
pancytokeratin in the skin. This observation is consistent with previous reports of increased
expression of cytokeratin following stimulation of keratinocytes with pro-inflammatory cyto-
kines [18]. IA UP-treatment resulted in increased IL-1β mRNA expression at 3d post-treatment
and increased IL-6 expression at 7d post-treatment. Although these studies were not designed
to accurately determine the ontogeny of skin responses to inflammatory agonist, it is apparent
that the skin is able to rapidly mount an inflammatory response to microbial agonist and, that
in the case of UP, this response persists for an extended period. In our experimental system it is
not possible to isolate the impact of systemic vs direct agonist inflammatory stimulation on the
fetal skin.
IA administration of IL-1β alone was not associated with pro-inflammatory changes in the
fetal skin. However, the co-administration of IL-1ra with LPS was associated with significant
reductions in IL-1β and IL-8 transcript expression, in the number of IL-6 positive cells in the
dermis, and in the intensity pancytokeratin staining relative to LPS-treatment only. Taken
together, these results demonstrate that both LPS and UP can induce fetal skin inflammation,
and, given that LPS-driven inflammatory responses are partially blocked with IA IL-1ra ther-
apy, that IL-1 signaling likely plays an important role in skin inflammation in utero.
Infection of amniotic fluid results in the production of proinflammatory cytokines and che-
mokines [19, 20]. The fetal skin, which has a large surface area, is entirely exposed to the amni-
otic fluid containing any invading microorganisms and proinflammatory agonists. Important
questions that remain unanswered are the relative importance of maternal or fetal inflamma-
tion, and which tissues (chorioamnion, placenta, fetal lung or fetal skin) are primarily respon-
sible for initiating the fetal inflammatory responses.
We suggest that the developing fetal skin may contribute to the acute fetal inflammatory
response (FIRS), which is associated with preterm birth and adverse neonatal outcomes. Even
a limited inflammatory fetal skin response could have systemic effects on the fetus due to a
large surface area and the high degree of vascularization. We previously showed in fetal sheep
that chorioamnionitis caused by the intra-amniotic injection of LPS resulted in inflammation,
particularly of the fetal lung, gut, skin, and chorioamnion [13, 21, 22]. IL-1 was central to this
inflammation as blockade of IL-1 signaling in the amniotic compartment with the same
recombinant IL-1 receptor antagonist (IL-1ra) largely inhibited the fetal lung and systemic
inflammation caused by intra-amniotic E. coli LPS [20]. The skin inflammatory response to
UP were modest but the evaluation was 3 and 7 days after IA injection of organisms. We antic-
ipate that there would be a longer interval from IA injection to an inflammation for UP than
LPS.
The proinflammatory cytokines IL-1β and TNF-α are considered primary mediators of sep-
tic shock and are also associated with infection-induced preterm delivery [16]. The robust
expression of IL-1 β by the primate fetal skin in response to IA LPS stimulation may be of sig-
nificance, given the association of these cytokines with infection-associated preterm labor.
Increases in IL-6 expression are frequently identified in association with preterm birth. IL-6 is
a marker of systemic fetal inflammatory response syndrome (cord blood IL-6>11 pg/mL) [2,
Skin inflammation in the primate fetus
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6, 19]. In the present study, IL-6 transcript expression in the fetal skin was increased signifi-
cantly only after 16 hours of LPS stimulation, but remained elevated 7d after UP exposure. IL-
8 is a potent chemotactant and neutrophil activating factor which is part of the response elic-
ited in the host against microbial invasion.
IL-8 also can recruit neutrophils to the fetal membranes and the placenta during the devel-
opment of an intrauterine infection. There was no significant change in IL-8 protein expres-
sion in response to UP administration at either 3d or 7d. Although IL-8 transcript expression
in the fetal skin was increased significantly both 16 and 48 hours post-LPS stimulation, we did
not observe infiltrating neutrophils (MPO), leukocytes (CD3+) or infiltrating macrophages
(CD68+) in fetal rhesus skin as we anticipated.
A possible explanation for these findings may be the structural immaturity of the fetal skin
which may allow immunocytes to move from the skin to the amniotic fluid. Previous studies
have suggested that fetal immunocytes (specifically, neutrophils, lymphocytes and monocytes)
are recruited into the amniotic fluid [22]. After IA LPS administration, immunocytes isolated
from the amniotic fluid expressed proinflammatory cytokine mRNA for IL-8 at 72 hours and
7 days while no cytokine mRNA can be detected in the chorioamnion, lung, or spleen after 72
hours [22]. The permeable nature of the developing fetal rhesus skin at early gestation may be
permissive for the transepidermal passage of cytokines and chemokines from the fetus into the
amniotic fluid [22].
In the present study, an injection of IL-1β sufficient to induce chorioamnionitis and fetal
inflammatory response [16] did not cause skin inflammation in the non-human primate. In a
related unpublished observation, IA IL-1β also did not cause skin inflammation in sheep (M.
Kemp, Personal Communication). This observation is of interest, given the importance of IL-1
signaling to skin inflammation, and the robust response seen in the macaque fetal lung and
chorioamnion in response to IL-1β stimulation. IL-1 is well established as a critical mediator
of skin inflammation, with both IL-1α and IL-1β acting via IL-1 receptor 1. Enk and col-
leagues, for example, have proposed that IL-1β produced by dendritic cells may be critical to
the induction of skin immune responses[23]. Dysregulation of the IL-1α: IL-1Ra ratio has
been implicated in a range of inflammatory skin diseases including psoriasis and contact der-
matitis [24].
Biologically active 31 kDa IL-1α is the predominant form expressed by epithelial cells,
including keratinocytes. In contrast, biologically active IL-1β is generated by cleavage of the 31
kDa inactive form by stimulated Langerhans cells, monocytes and macrophages. Although
keratinocytes also generate the biologically inactive 31kDa IL-1β precursor, they largely lack
the enzyme necessary to complete significant post-translational generation of the mature 17
kDa protein [25].
It is tempting to speculate as to why 10 ug of IA IL-1β failed to elicit skin inflammation in
the macaque fetus, despite being associated with pulmonary inflammation and chorioamnio-
nitis. Firstly, it is possible that there was insufficient IL1R available in the fetal skin to drive a
detectable inflammatory response to IL-1β stimulation. Using newborn human foreskin sam-
ples, Groves and colleagues demonstrated that in contrast to adult human skin (which demon-
strates robust basal and apical epidermal IL-1R staining [26]) untreated tissues expressed very
few IL-1R (either type 1 or 2), although significant and rapid increases in the expression of the
type-II (inhibitory) IL-1R could be induced by tissue stimulation with interferon-ɣ, or by over-
night incubation at 37˚C [27]. In contrast, Toll-like receptors (including Toll-like receptor 4,
which is strongly agonized by LPS) are expressed in skin from an early gestational age, likely
facilitating the LPS-driven response identified in the present report[28]. However, against this
hypothesis is our observation that IL-1Ra was able to antagonize LPS-driven inflammation,
which itself requires the binding of IL-1Ra to type I IL-1R.
Skin inflammation in the primate fetus
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Secondly, it is possible that the dose of IL-1β administered was insufficient to overcome
inhibition of IL-1R1 signaling by endogenously expressed IL1Ra, although given the high
ration of IL-1Ra: IL1 required to inhibit productive signaling (ranging between 10:1 and 100:1
[24]), this explanation also seems unlikely. Thirdly, it is possible that the magnitude of inflam-
matory response generated by IL-1β stimulation were too small to be identified statistically
with the group sizes used in our study. Lastly, unlike in the fetal lung, it is possible that IL-1β-
driven responses in the skin are acute, modest, and resolve within 24h.
There are a number of clinical correlations of this study. In chorioamnionitis-induced fetal
inflammatory response, the fetal skin may contribute to the inflammation in the amniotic
fluid and systemically. Furthermore, skin inflammation could further compromise the already
poor barrier function of the fetus or decrease the permeability by the increased cornification.
Infants exposed to chorioamnionitis could have an increased predisposition to nosocomial
infection from alterations in skin barrier function. IA IL-1ra therapy can block the inflamma-
tory responses in primate fetal skin and FIRS from LPS, the receptor blockers may both block
preterm delivery and fetal injury.
In conclusion, the primate fetal skin can mount an inflammatory response to in utero
inflammation, although this response is modest and appears to lack an immunocyte response,
at least acutely. However, given the size, degree of vascularization, and direct exposure to the
amniotic fluid, the primate fetal skin may be an important source of the both fetal inflamma-
tion and pro-inflammatory mediators that could signal the chorioamnion, cervix, and uterus
to ultimately induce preterm labor.
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